重症监护病房鲍曼不动杆菌耐药性分析及对策

目的分析ICU病房鲍曼不动杆菌（ABA）耐药情况和临床特点,为预防和控制ABA的感染提供依据。方法对本院2009年1月～2010年5月ICU病房患者送检标本中分离的鲍曼不动杆菌的病区分布情况与耐药性进行回顾性分析。结果 ABA对常用药都很耐药,仅对亚胺培南、左氧氟沙星的耐药率较低为42.4%和46.3%,泛耐药株检出率达7.8%。结论 ABA在ICU病房的感染较为严重,而且耐药性很高。必须采取相应的防治和监控措施,预防ABA的高耐药性和多重耐药性造成的医院感染。

Drug Resistance analysis and counter measure of acinetobacter baumanii in intensive care unit

Objective To analyze the condition of drug resistance and clinical characteristics of acinetobacter baumannnii in ICU ward for the purpose of providing reference with lower infection. Methods The distribution of endemic areas and drug resistance of acinetobacter baumannii isolated from the spcimens of the inpatients in ICU ward from January 2009 to May 2010 were analyzed retrospectively. Resluts ABA was resistant to commonly used antibiotics, the lower resistance rates to imipenem and evofloxacin were 42.4% and 46.3%. The isolated rate of panresistant stains was 7.8%. Conclusion Acinetobacter baumannii in ICU infection is most serous and the drug resistance rate was much higher. We must take preventive measures to monitoring of drug resistance in ABA and to prevent nosocomial infections with multidrug resistant strains.